Table 2 Levels of comorbidities, mortality risk (Charlson score), and use of medication and medical healthcare in the whole study population and in patients across the three practices studied
CharacteristicAll (n = 300)GP (n = 100)DNS (n = 100)MS (n = 100)p Value for trend
Lifetime comorbidities per person (No)
    Total7.0 (0.2)5.7 (0.3)6.5 (0.3)8.7 (0.4)<0.001
    Complicating5.0 (0.2)3.6 (0.3)4.7 (0.3)6.7 (0.3)<0.001
    Concurrent2.0 (0.1)2.1 (0.2)1.8 (0.2)2.0 (0.2)0.799
Mortality risk (Charlson Index score)4.5 (0.1)3.9 (0.2)4.4 (0.2)5.3 (0.2)<0.001
Medication use (No)
    Total6.6 (0.2)6.3 (0.3)6.6 (0.3)7.0 (0.3)0.125
    Diabetes-related5.0 (0.1)4.6 (0.2)5.1 (0.2)5.5 (0.3)0.017
Medical healthcare use (No)
    Specialties involved4.0 (0.1)3.3 (0.2)3.8 (0.2)4.9 (0.2)<0.001
    Consultations17.1 (1.1)9.8 (1.3)13.2 (1.1)38.4 (1.1)<0.001
  • GP, general practice; DNS, diabetes nurse specialist practice; MS medical specialist practice

  • Data are mean (SE); all analyses were adjusted for age, sex and HbA1c.